Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ
Tải xuống
Tuyển tập các báo cáo nghiên cứu về hóa học được đăng trên tạp chí hóa học đề tài : Responsiveness and minimal important differences for patient reported outcomes | BioMed Central Health and Quality of Life Outcomes Open Access Responsiveness and minimal important differences for patient reported outcomes Dennis A Revicki 1 David Cella2 Ron D Hays3 Jeff A Sloan4 William R Lenderking5 and Neil K Aaronson6 Address 1Center for Health Outcomes Research United Biosource Corporation 7101 Wisconsin Ave. Suite 600 Bethesda MD 20814 USA 2Evanston Northwestern Healthcare Center on Outcomes Research and Education Evanston IL USA 3UCLA Division of General Internal Medicine and Health Services Research 911 Broxton Plaza Room 110 Los Angeles CA 90024 USA 4Department of Health Sciences Research Mayo Clinic 200 First Street SW Rochester MN 55905 USA 5Worldwide Outcomes Research Pfizer Inc. Eastern Point Road Groton CT 06340 USA and 6Division of Psychosocial Research and Epidemiology The Netherlands Cancer Institute Plesmanlaan 121 1066CX Amsterdam The Netherlands Email Dennis A Revicki - dennis.revicki@unitedbiosource.com David Cella - d-cella@northwestern.edu Ron D Hays - drhays@ucla.edu Jeff A Sloan - jsloan@mayo.edu William R Lenderking - william.r.lenderking@pfizer.com Neil K Aaronson - naaron@nki.nl Corresponding author Published 27 September 2006 Received 21 September 2006 U.LL J . A.Zinn in J n I I n 11 11 r in Accepted 27 September 2006 Health and Quality of Life Outcomes 2006 4 70 doi l0.ll86 l477-7525-4-70 This article is available from http www.hqlo.cOm content 4 1 70 2006 Revicki et al licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License http creativecommons.org licenses by 2.0 which permits unrestricted use distribution and reproduction in any medium provided the original work is properly cited. Abstract__ Patient reported outcomes provide the patient s perspective on the effectiveness of treatment. The draft Food and Drug Administration guidance on patient reported outcomes
